De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Charles & Colvard Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Don O'Connell

Algemeen directeur

US$578.4k

Totale compensatie

Percentage CEO-salaris	61.8%
Dienstverband CEO	4.3yrs
Eigendom CEO	2.4%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	10.3yrs

Recente managementupdates

Recent updates

Investors Don't See Light At End Of Charles & Colvard, Ltd.'s (NASDAQ:CTHR) Tunnel

Sep 26

Charles & Colvard, Ltd.'s (NASDAQ:CTHR) 26% Dip In Price Shows Sentiment Is Matching Revenues

Jun 12

Charles & Colvard, Ltd.'s (NASDAQ:CTHR) Business Is Yet to Catch Up With Its Share Price

Jan 23

Charles & Colvard Is Leading The Way In 'Made, Not Mined' Jewelry - High Return Potential

May 16

Silver Ring Value Partners - Charles & Colvard: Exited In Q4

Feb 22

Charles & Colvard (NASDAQ:CTHR) Is Doing The Right Things To Multiply Its Share Price

Dec 24

Charles & Colvard: While Diamonds Are A Girl's Best Friend, They Can Be An Investor's Best Bet

Dec 01

Charles & Colvard (NASDAQ:CTHR) Shareholders Will Want The ROCE Trajectory To Continue

Aug 26

Upgrade: Analysts Just Made A Sizeable Increase To Their Charles & Colvard, Ltd. (NASDAQ:CTHR) Forecasts

May 13

Charles & Colvard, Ltd. 2021 Q3 - Results - Earnings Call Presentation

May 08

We Like These Underlying Return On Capital Trends At Charles & Colvard (NASDAQ:CTHR)

Mar 31

Charles & Colvard, Ltd. Just Beat EPS By 200%: Here's What Analysts Think Will Happen Next

Feb 06

If You Had Bought Charles & Colvard (NASDAQ:CTHR) Stock Five Years Ago, You Could Pocket A 97% Gain Today

Jan 30

Insider Buying: The Charles & Colvard, Ltd. (NASDAQ:CTHR) Independent Director Just Bought 5.1% More Shares

Nov 20

Charles & Colvard Is A Growth ESG Company Trading Below Book

Nov 17

Analyse CEO-vergoeding

Hoe is Don O'Connell's beloning veranderd ten opzichte van Charles & Colvard's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Mar 31 2024	n/a	n/a	-US$18m
Dec 31 2023	n/a	n/a	-US$23m
Sep 30 2023	n/a	n/a	-US$21m
Jun 30 2023	US$578k	US$357k	-US$20m
Mar 31 2023	n/a	n/a	-US$10m
Dec 31 2022	n/a	n/a	-US$2m
Sep 30 2022	n/a	n/a	US$657k
Jun 30 2022	US$1m	US$347k	US$2m
Mar 31 2022	n/a	n/a	US$11m
Dec 31 2021	n/a	n/a	US$11m
Sep 30 2021	n/a	n/a	US$13m
Jun 30 2021	US$444k	US$335k	US$13m
Mar 31 2021	n/a	n/a	US$3m
Dec 31 2020	n/a	n/a	-US$4m
Sep 30 2020	n/a	n/a	-US$5m
Jun 30 2020	US$596k	US$289k	-US$6m
Mar 31 2020	n/a	n/a	-US$5m
Dec 31 2019	n/a	n/a	US$2m
Sep 30 2019	n/a	n/a	US$2m
Jun 30 2019	US$340k	US$283k	US$2m
Mar 31 2019	n/a	n/a	US$1m
Dec 31 2018	n/a	n/a	US$24k
Sep 30 2018	n/a	n/a	-US$482k
Jun 30 2018	US$346k	US$138k	-US$767k
Mar 31 2018	n/a	n/a	-US$472k
Dec 31 2017	US$394k	US$252k	-US$453k

Compensatie versus markt: De totale vergoeding ($USD 578.37K ) Don } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 677.23K ).

Compensatie versus inkomsten: De vergoeding van Don is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Don O'Connell (57 yo)

4.3yrs

Tenure

US$578,368

Compensatie

Mr. Don O'Connell serves as the President, Chief Executive Officer & Director of Charles & Colvard, Ltd. since June 1, 2020. He had been Chief Operating Officer and Senior Vice President of Supply Chain at...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Don O'Connell	President	4.3yrs	US$578.37k	2.37% $ 124.3k
Neal Goldman	Independent Chairman	10.3yrs	US$84.22k	4.08% $ 213.5k
Ollin Sykes	Independent Director	16.4yrs	US$71.11k	6.73% $ 352.4k
Anne Butler	Independent Director	12.3yrs	US$76.11k	1.2% $ 62.7k
Benedetta Casamento	Independent Director	7.4yrs	US$81.11k	0.76% $ 39.9k

10.3yrs

Gemiddelde duur

73yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CTHR zijn ervaren en ervaren (gemiddelde ambtstermijn van 10.3 jaar).

Charles & Colvard Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Insufficient new directors

Charles & Colvard, Ltd., Annual General Meeting, Dec 14, 2023

Insufficient new directors

Insider recently bought US$204k worth of stock

Insider recently bought US$1.6m worth of stock

Charles & Colvard, Ltd., Annual General Meeting, Nov 17, 2022

Recent updates

Charles & Colvard, Ltd. announced delayed annual 10-K filing

Investors Don't See Light At End Of Charles & Colvard, Ltd.'s (NASDAQ:CTHR) Tunnel

New minor risk - Share price stability

Charles & Colvard, Ltd.'s (NASDAQ:CTHR) 26% Dip In Price Shows Sentiment Is Matching Revenues

Charles & Colvard Approves 1-for-10 Reverse Split to Bring it into Compliance with Nasdaq's Minimum Bid Price Requirement for Continued Listing

Third quarter 2024 earnings released: US$0.12 loss per share (vs US$0.28 loss in 3Q 2023)

Charles & Colvard, Ltd. to Report Q3, 2024 Results on May 02, 2024

New minor risk - Share price stability

New major risk - Market cap size

Second quarter 2024 earnings released: US$0.094 loss per share (vs US$0.034 loss in 2Q 2023)

Charles & Colvard, Ltd. to Report Q2, 2024 Results on Feb 13, 2024

Charles & Colvard, Ltd.'s (NASDAQ:CTHR) Business Is Yet to Catch Up With Its Share Price

Insufficient new directors

Charles & Colvard Receives Notification Letter from Nasdaq Regarding Eligible for an Additional 180-Day Grace Period, or Until June 10, 2024 to Regain Compliance with the Minimum Bid Price Requirement

Charles & Colvard, Ltd. to Report Q1, 2024 Results on Nov 09, 2023

Charles & Colvard, Ltd., Annual General Meeting, Dec 14, 2023

Charles & Colvard, Ltd. to Report Q4, 2023 Results on Oct 12, 2023

Charles & Colvard, Ltd. Provides Earnings Guidance for the Fiscal Year Ended June 30, 2023

Insufficient new directors

Charles & Colvard Receives Notification Letter from Nasdaq’s Listing Qualifications Department Indicating that the Company Is Not in Compliance with Nasdaq Listing Rule 5550(a)(2)

Insider recently bought US$204k worth of stock

Third quarter 2023 earnings released: US$0.28 loss per share (vs US$0.011 profit in 3Q 2022)

Insider recently bought US$1.6m worth of stock

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Charles & Colvard, Ltd. to Report Q2, 2023 Results on Feb 02, 2023

Charles & Colvard Receives A Notification Letter from Nasdaq Regarding Minimum Bid Price

Consensus EPS estimates fall by 200%

Consensus EPS estimates fall by 200%

First quarter 2023 earnings released: US$0.029 loss per share (vs US$0.028 profit in 1Q 2022)

Charles & Colvard, Ltd. to Report Q1, 2023 Results on Nov 03, 2022

Charles & Colvard Launches Lab Grown Precious Gemstones Giving Their Conscious Fine Jewelry Bold New Color

Charles & Colvard: Lab Grown Diamonds Can Survive A Recession

Charles & Colvard, Ltd., Annual General Meeting, Nov 17, 2022

Charles & Colvard® Expands Signature Collection to Include All New Lab Grown Diamond Men's Bands

Consensus EPS estimates have been downgraded.

President exercised options and sold US$53k worth of stock

Investors Will Want Charles & Colvard's (NASDAQ:CTHR) Growth In ROCE To Persist

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Charles & Colvard Q4 2022 Earnings Preview

Charles & Colvard, Ltd. to Report Q4, 2022 Results on Sep 01, 2022

Charles & Colvard Redefines Conscious Luxury with New Lab Grown Diamond Couture Collection

Charles & Colvard Redefines Conscious Luxury with New Lab Grown Diamond Couture Collection

Charles & Colvard, Ltd.(NasdaqCM:CTHR) dropped from Russell 3000E Growth Index

Independent Chairman recently bought US$103k worth of stock

Charles & Colvard Is Leading The Way In 'Made, Not Mined' Jewelry - High Return Potential

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Charles & Colvard, Ltd. (NasdaqCM:CTHR) announces an Equity Buyback for $5 million worth of its shares.

Price target decreased to US$3.25

Charles & Colvard, Ltd. to Report Q3, 2022 Results on May 05, 2022

Silver Ring Value Partners - Charles & Colvard: Exited In Q4

Independent Chairman exercised options to buy US$89k worth of stock.

Consensus forecasts updated

Price target decreased to US$3.25

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Charles & Colvard (NASDAQ:CTHR) Is Doing The Right Things To Multiply Its Share Price

Independent Director exercised options to buy US$466k worth of stock.

Charles & Colvard: While Diamonds Are A Girl's Best Friend, They Can Be An Investor's Best Bet

First quarter 2022 earnings released: EPS US$0.028 (vs US$0.03 in 1Q 2021)

Independent Director exercised options to buy US$246k worth of stock.

Full year 2021 earnings released: EPS US$0.44 (vs US$0.21 loss in FY 2020)

Charles & Colvard (NASDAQ:CTHR) Shareholders Will Want The ROCE Trajectory To Continue

Independent Chairman exercised options to buy US$128k worth of stock.

Investor sentiment improved over the past week

Upgrade: Analysts Just Made A Sizeable Increase To Their Charles & Colvard, Ltd. (NASDAQ:CTHR) Forecasts

Charles & Colvard, Ltd. 2021 Q3 - Results - Earnings Call Presentation

We Like These Underlying Return On Capital Trends At Charles & Colvard (NASDAQ:CTHR)

Independent Chairman exercised options to buy US$175k worth of stock.

New 90-day high: US$2.80

Independent Director exercised options to buy US$135k worth of stock.